
-
Daniel R Kuritzkes, MD
Professor
Harvard Medical School
- Know how to define persistent low-level viremia and differentiate it from early HIV treatment failure.
- Understand the mechanisms of persistent low-level viremia.
- Be able to provide guidance for management of patients with persistent low-level viremia.

This CME activity was approved for AMA PRA Category 1 Credit™ on December 17, 2019 and will terminate December 16, 2022.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Disclosure Statement
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
- Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
- Daniel R. Kuritzkes, MD (Presenter) had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research Support from Abbvie, Gilead, Merck, and ViiV; Consultant to Gilead, GlaxoSmithKline, Merck, and ViiV; Speaking Honorarium from Janssen. Dr. Kurtizkes submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.
Details:
- This online video and post-activity evaluation are one hour in length.
- After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
- You must achieve at least 70% correct to receive your CME certificate.
- If successful, you will be provided instructions to print your CME certificate at the completion of this activity.